Deals

METiS TechBio Partners with Eli Lilly on AI‑Driven Lipid Nanoparticle Delivery – Up to USD 1.1 Billion in Milestones for Tissue‑Specific LNP Discovery
Eli LillyHKG: 7666

METiS TechBio Partners with Eli Lilly on AI‑Driven Lipid Nanoparticle Delivery – Up to USD 1.1 Billion in Milestones for Tissue‑Specific LNP Discovery

METiS TechBio (HKG: 7666), an innovative AI drug delivery company, announced a strategic collaboration with Eli Lilly and Company (NYSE: LLY) focused on the research and discovery of novel lipid…

Hansoh Pharma Strikes Second ADC Licensing Deal with Roche – USD 400 Million Upfront, Over USD 15 Billion in Potential Milestones

Hansoh Pharma Strikes Second ADC Licensing Deal with Roche – USD 400 Million Upfront, Over USD 15 Billion in Potential Milestones

Insilico Medicine Earns Milestone Payment from Servier – First Oncology Program Hits Early‑Stage Drug Discovery Mark on Pharma.AI Platform

Insilico Medicine Earns Milestone Payment from Servier – First Oncology Program Hits Early‑Stage Drug Discovery Mark on Pharma.AI Platform

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Formosa Pharmaceuticals Licenses Clobetasol Propionate to Apotex for Mexico
ApotexFormosa Pharmaceuticals

Formosa Pharmaceuticals Licenses Clobetasol Propionate to Apotex for Mexico

Novartis to Acquire Regulus Therapeutics for Up to $1.7 Billion
NASDAQ: RGLSNovartis

Novartis to Acquire Regulus Therapeutics for Up to $1.7 Billion

Nanjing Perlove Medical Equipment Files IPO Application in Hong Kong
IPOPerlove Medical Equipment

Nanjing Perlove Medical Equipment Files IPO Application in Hong Kong

Sanofi's Opella Becomes Independent Consumer Healthcare Company After CD&R Deal
Clayton Dubilier & RiceNASDAQ: SNY

Sanofi’s Opella Becomes Independent Consumer Healthcare Company After CD&R Deal

Show More